Share this article
Windtree’s BNB Treasury Bet Collides With Nasdaq Delisting Order
Biotech firm Windtree touted itself as the first Nasdaq-listed company to build a BNB treasury. Weeks later, the Securities and Exchange Commission ordered it delisted.
Aug 21, 2025, 6:17 a.m.
What to know:
- Windtree Therapeutics will be delisted from the Nasdaq on August 21 due to failing to meet the $1 minimum bid price requirement.
- The company plans to transition to over-the-counter trading, though it cannot guarantee the success of this move.
- Windtree's shares plummeted nearly 80% after the delisting announcement, closing at 11 cents.
Windtree Therapeutics’ high-profile plan to raise up to $200 million for a BNB treasury has run headlong into a market reality check: the Nasdaq is kicking it off the exchange.
The Warrington, Pennsylvania-based biotech disclosed in a Tuesday filing that the Nasdaq Capital Market will suspend trading in its shares effective Aug. 21 after the company failed to meet the $1 minimum bid price required under Nasdaq Listing Rule 5550(a)(2).
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
Windtree expects to transition to over-the-counter trading under its existing symbol “WINT,” though it cannot guarantee that the plan will go through, it said in a filing.
The delisting undercuts Windtree’s July announcement that it would become the first Nasdaq-listed company to build a BNB treasury.
At the time, the company unveiled a $60 million securities purchase agreement with blockchain infrastructure investor Build and Build Corp., with the potential to scale the program to $200 million. Shares surged more than 20% in pre-market trading after the news last month, but the company could not maintain the important $1 mark to maintain its listing.
Windtree's stock slumped through most of late July and August, trading at 48 cents before the delisting announcement.
The move was positioned as an echo of Michael Saylor’s Strategy (MSTR), which has turned its balance sheet into a bitcoin proxy. But unlike Strategy, which remains a Nasdaq bellwether, Windtree will now be relegated to OTC markets, limiting its visibility and institutional reach.
Shares dropped nearly 80% after the company disclosed the delisting order, and closed at 11 cents.
Read more: Biotech Company Windtree to Raise Up to $200M for BNB Treasury
More For You
What to know:
- As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
- GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
- Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.
More For You
Bitcoin Market Echoes Early 2022 as Onchain Stress Mounts: Glassnode
Rising bitcoin supply in loss, weakening spot demand and cautious derivatives positioning were among the issues raised by the data provider in its weekly newsletter.
What to know:
- Glassnode's weekly newsletter shows multiple onchain metrics now resemble conditions seen at the start of the 2022 bear market, including elevated top buyer stress and a sharp rise in supply held at a loss.
- Off chain indicators show softening demand and fading risk appetite, with declining ETF flows and weakening spot volumes.
Top Stories
